BioSpace News Archive

Genetown

Moderna On Track for Early Data Readout for COVID-19 Vaccine This Month

The company said they needed 53 patients in the study to be diagnosed with COVID-19, and the trial hit that figure yesterday.

November 12, 2020
·
3 min read
·
Mark Terry
Career Advice

Should You Change Careers During a Pandemic?

If you’re contemplating changing careers in the midst of the COVID-19 pandemic, the reality is that if it’s time to make a change, there’s no time like the present.

November 12, 2020
·
3 min read
·
Kymberlie Krieger
BioCapital

New Targeted Approach Could Prevent Toxicities Associated with Neurological Gene Therapies

Researchers from Penn Medicine have developed a new targeted approach that modifies viral vectors and inhibits toxicities in the sensory neurons of dorsal root ganglia that commonly occur following the use of gene therapy for neurological diseases.

November 12, 2020
·
2 min read
·
Brandon May
Drug Development

AstraZeneca’s Calquence Fails Pair of Phase II COVID-19 Trials

AstraZeneca reported that the CALAVI Phase II trials of Calquence (acalabrutinib) in hospitalized patients with respiratory symptoms of COVID-19 failed to meet the trials’ primary efficacy endpoint.

November 12, 2020
·
3 min read
·
Mark Terry
Drug Development

NECI’s Digital Stack Helps Moderna Create its COVID-19 Vaccine in Record Time

Integrating digital tools for manufacturing process development, control and data analytics brings data together in ways that enhance visibility system-wide.

November 12, 2020
·
4 min read
·
Gail Dutton
Business

Blast Off! Two Companies Launch with Millions in Financing to Develop New Therapies

Two new companies exploded onto the scene this morning, backed by significant financing that will be used to develop treatments for a wide range of diseases.

November 12, 2020
·
4 min read
·
Alex Keown
Deals

UCB Flexes M&A Muscles to Bolster its Gene Therapy Capabilities

This morning, the company announced it bolstered its own gene therapy activities with the acquisition of Handl Therapeutics BV, a rapidly growing and transformative gene therapy company.

November 12, 2020
·
3 min read
·
Alex Keown
Research Roundup: COVID-19 and Psychiatric Disorders and More

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

November 12, 2020
·
5 min read
·
Mark Terry
Business

Getting to Know Dr. James Garner, CEO of Kazia Therapeutics

BioSpace recently spoke with Dr. James Garner, CEO of Kazia Therapeutics, an oncology company that is focused on the development of cancer drugs.

November 12, 2020
·
5 min read
·
Gina Hagler
Drug Development

Five Prime Celebrates Many Firsts in Positive Phase II Cancer Trial

Five Prime Therapeutics Inc., in collaboration Zai Lab Limited on the development bemarituzumab, a novel therapy for front-line advanced non HER2+ gastric or gastroesophageal junction (GEJ) cancer, on Wednesday announced groundbreaking positive topline Phase II results.

November 12, 2020
·
3 min read
·
Heather McKenzie